Search research articles
Contact Us
Filters
Showing results (351-360 of 362) with videos related to
Page
of 37
Sort By:
Inflammatory Bowel Diseases
|
February 2, 2012
Doubling the infliximab dose versus halving the infusion intervals in Crohn's disease patients with loss of response
Lior Katz, Javier P Gisbert, Beth Manoogian, et al.
Alimentary Pharmacology & Therapeutics
|
June 7, 2018
Antigenic response to CT-P13 and infliximab originator in inflammatory bowel disease patients shows similar epitope recognition
J Goncalves, M Santos, R Acurcio, et al.
Inflammatory Bowel Diseases
|
June 8, 2017
Impact of Infliximab and Cyclosporine on the Risk of Colectomy in Hospitalized Patients with Ulcerative Colitis Complicated by Cytomegalovirus-A Multicenter Retrospective Study
Uri Kopylov, Konstantinos Papamichael, Konstantinos Katsanos, et al.
Alimentary Pharmacology & Therapeutics
|
May 16, 2020
Effectiveness of ustekinumab dose escalation in Crohn's disease patients with insufficient response to standard-dose subcutaneous maintenance therapy
Uri Kopylov, Jurij Hanzel, Claire Liefferinckx, et al.
JCI Insight
|
June 1, 2023
Mucosal transcriptomics highlight lncRNAs implicated in ulcerative colitis, Crohn's disease, and celiac disease
Tzipi Braun, Katya E Sosnovski, Amnon Amir, et al.
Inflammatory Bowel Diseases
|
May 23, 2018
Effectiveness and Safety of Vedolizumab in Anti-TNF-Naïve Patients With Inflammatory Bowel Disease-A Multicenter Retrospective European Study
Uri Kopylov, Bram Verstockt, Luc Biedermann, et al.
Journal of Crohn'S & Colitis
|
July 31, 2025
ECCO-ESGAR-ESP-IBUS Guideline on Diagnostics and Monitoring of Patients with Inflammatory Bowel Disease: Part 1
Torsten Kucharzik, Stuart Taylor, Mariangela Allocca, et al.
Gastroenterology
|
October 31, 2021
Lower Serologic Response to COVID-19 mRNA Vaccine in Patients With Inflammatory Bowel Diseases Treated With Anti-TNFα
Hadar Edelman-Klapper, Eran Zittan, Ariella Bar-Gil Shitrit, et al.
Journal of Crohn'S & Colitis
|
June 10, 2025
The effectiveness of second- and-third-line biologics in perianal Crohn's disease-a multicenter propensity score-matched study
Uria Shani, Monica State, Radu Bogdan Mateescu, et al.
Vaccines
|
March 26, 2022
COVID-19 in Patients with Inflammatory Bowel Disease: The Israeli Experience
Lev Lichtenstein, Benjamin Koslowsky, Ami Ben Ya'acov, et al.
Page
of 37
Search research articles
Search
Showing results (351-360 of 362) with videos related to
Sort By:
Page
of 37
Inflammatory Bowel Diseases
|
February 2, 2012
Doubling the infliximab dose versus halving the infusion intervals in Crohn's disease patients with loss of response
Lior Katz, Javier P Gisbert, Beth Manoogian, et al.
Alimentary Pharmacology & Therapeutics
|
June 7, 2018
Antigenic response to CT-P13 and infliximab originator in inflammatory bowel disease patients shows similar epitope recognition
J Goncalves, M Santos, R Acurcio, et al.
Inflammatory Bowel Diseases
|
June 8, 2017
Impact of Infliximab and Cyclosporine on the Risk of Colectomy in Hospitalized Patients with Ulcerative Colitis Complicated by Cytomegalovirus-A Multicenter Retrospective Study
Uri Kopylov, Konstantinos Papamichael, Konstantinos Katsanos, et al.
Alimentary Pharmacology & Therapeutics
|
May 16, 2020
Effectiveness of ustekinumab dose escalation in Crohn's disease patients with insufficient response to standard-dose subcutaneous maintenance therapy
Uri Kopylov, Jurij Hanzel, Claire Liefferinckx, et al.
JCI Insight
|
June 1, 2023
Mucosal transcriptomics highlight lncRNAs implicated in ulcerative colitis, Crohn's disease, and celiac disease
Tzipi Braun, Katya E Sosnovski, Amnon Amir, et al.
Inflammatory Bowel Diseases
|
May 23, 2018
Effectiveness and Safety of Vedolizumab in Anti-TNF-Naïve Patients With Inflammatory Bowel Disease-A Multicenter Retrospective European Study
Uri Kopylov, Bram Verstockt, Luc Biedermann, et al.
Journal of Crohn'S & Colitis
|
July 31, 2025
ECCO-ESGAR-ESP-IBUS Guideline on Diagnostics and Monitoring of Patients with Inflammatory Bowel Disease: Part 1
Torsten Kucharzik, Stuart Taylor, Mariangela Allocca, et al.
Gastroenterology
|
October 31, 2021
Lower Serologic Response to COVID-19 mRNA Vaccine in Patients With Inflammatory Bowel Diseases Treated With Anti-TNFα
Hadar Edelman-Klapper, Eran Zittan, Ariella Bar-Gil Shitrit, et al.
Journal of Crohn'S & Colitis
|
June 10, 2025
The effectiveness of second- and-third-line biologics in perianal Crohn's disease-a multicenter propensity score-matched study
Uria Shani, Monica State, Radu Bogdan Mateescu, et al.
Vaccines
|
March 26, 2022
COVID-19 in Patients with Inflammatory Bowel Disease: The Israeli Experience
Lev Lichtenstein, Benjamin Koslowsky, Ami Ben Ya'acov, et al.
Page
of 37